Theravance Biopharma
TBPH
TBPH
83 hedge funds and large institutions have $226M invested in Theravance Biopharma in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
100% less call options, than puts
Call options by funds: $4K | Put options by funds: $989K
Holders
83
Holding in Top 10
1
Calls
$4K
Puts
$989K
Top Buyers
| 1 | +$3.96M | |
| 2 | +$1.4M | |
| 3 | +$1.1M | |
| 4 |
Millennium Management
New York
|
+$856K |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$822K |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$4.84M | |
| 3 | -$4.68M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$3.63M |
| 5 |
Renaissance Technologies
New York
|
-$3.44M |